Back to Search Start Over

Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals.

Authors :
Samonakis DN
Psyllaki M
Pavlaki KI
Drakos E
Kehagias E
Tzardi M
Papadaki HA
Source :
Annals of hepatology [Ann Hepatol] 2021 Mar-Apr; Vol. 21, pp. 100141. Date of Electronic Publication: 2019 Oct 03.
Publication Year :
2021

Abstract

The association of Non-Hodgkin lymphomas and Hepatitis C virus is well documented and antiviral treatments facilitate a virological and hematological response in the majority of HCV related Non-Hodgkin lymphomas. The recent years, direct acting antivirals have made cure possible almost for every HCV patient. Some concerns were raised as regards the frequency and the pattern of recurrence in HCV patients with HCC, treated with these agents. We present a patient with DLBCL, in remission after appropriate treatment, HCV cirrhosis that was cured with the new antivirals and shortly after SVR, he experienced a lethal lymphoma recurrence.<br /> (Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.)

Details

Language :
English
ISSN :
1665-2681
Volume :
21
Database :
MEDLINE
Journal :
Annals of hepatology
Publication Type :
Academic Journal
Accession number :
31694799
Full Text :
https://doi.org/10.1016/j.aohep.2019.08.012